{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:41:14Z","timestamp":1792089674268,"version":"4.4.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,16]]},"DOI":"10.7759\/cureus.13384","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:15:25Z","timestamp":1613560525000},"source":"Crossref","is-referenced-by-count":6,"title":["Iatrogenic Kaposi Sarcoma Precipitated by Anti-Tumor Necrosis Factor-Alpha (Anti-TNF-\u03b1) Therapy"],"prefix":"10.7759","author":[{"given":"Aathi Lakshmi","family":"Mariappan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Locante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javairia","family":"Quraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0275","article-title":"Kaposi sarcoma herpesvirus pathogenesis","volume":"372","author":"Mariggi\u00f2 G","year":"2017","unstructured":"Mariggi\u00f2 G, Koch S, Schulz TF. Kaposi sarcoma herpesvirus pathogenesis. Philos Trans R Soc Lond B Biol Sci. 2017, 372:20160275. 10.1098\/rstb.2016.0275","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14080","article-title":"Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant","volume":"58","author":"Vangipuram R","year":"2019","unstructured":"Vangipuram R, Tyring SK. Epidemiology of Kaposi sarcoma: review and description of the nonepidemic variant. Int J Dermatol. 2019, 58:538-542. 10.1111\/ijd.14080","journal-title":"Int J Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_217_18","article-title":"The spectrum of underlying causes of iatrogenic Kaposi's sarcoma in a large series: a retrospective study","volume":"64","author":"Baykal C","year":"2019","unstructured":"Baykal C, Atci T, Buyukbabani N, Kutlay A. The spectrum of underlying causes of iatrogenic Kaposi's sarcoma in a large series: a retrospective study. Indian J Dermatol. 2019, 64:392-399. 10.4103\/ijd.IJD_217_18","journal-title":"Indian J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.08.014","article-title":"Molecular mechanisms of action of anti-TNF-\u03b1 agents - comparison among therapeutic TNF-\u03b1 antagonists","volume":"101","author":"Mitoma H","year":"2018","unstructured":"Mitoma H, Horiuchi T, Tsukamoto H, Ueda N. Molecular mechanisms of action of anti-TNF-\u03b1 agents - comparison among therapeutic TNF-\u03b1 antagonists. Cytokine. 2018, 101:56-63. 10.1016\/j.cyto.2016.08.014","journal-title":"Cytokine"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker113","article-title":"Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis","volume":"50","author":"Amari W","year":"2011","unstructured":"Amari W, Zeringue AL, McDonald JR, Caplan L, Eisen SA, Ranganathan P. Risk of non-melanoma skin cancer in a national cohort of veterans with rheumatoid arthritis. Rheumatology (Oxford). 2011, 50:1431-1439. 10.1093\/rheumatology\/ker113","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/art.22864","article-title":"Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study","volume":"56","author":"Wolfe F","year":"2007","unstructured":"Wolfe F, Michaud K. Biologic treatment of rheumatoid arthritis and the risk of malignancy: analyses from a large US observational study. Arthritis Rheum. 2007, 56:2886-2895. 10.1002\/art.22864","journal-title":"Arthritis Rheum"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1066896917736610","article-title":"Iatrogenic Kaposi's sarcoma in an HIV-negative young male with Crohn's disease and IgA nephropathy: a case report and brief review of the literature","volume":"26","author":"Windon AL","year":"2018","unstructured":"Windon AL, Shroff SG. Iatrogenic Kaposi's sarcoma in an HIV-negative young male with Crohn's disease and IgA nephropathy: a case report and brief review of the literature. Int J Surg Pathol. 2018, 26:276-282. 10.1177\/1066896917736610","journal-title":"Int J Surg Pathol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S1578-2190(10)70676-4","article-title":"Sarcoma de Kaposi asociado al tratamiento con infliximab [Article in Spanish]","volume":"101","author":"Mart\u00ednez-Mart\u00ednez ML","year":"2010","unstructured":"Mart\u00ednez-Mart\u00ednez ML, P\u00e9rez-Garc\u00eda LJ, Escario-Travesedo E, Ribera-Vaquerizo PA. Sarcoma de Kaposi asociado al tratamiento con infliximab [Article in Spanish]. Actas Dermosifiliogr. 2010, 101:462-464. 10.1016\/S1578-2190(10)70676-4","journal-title":"Actas Dermosifiliogr"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.7.684","article-title":"Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy","volume":"62","author":"Cohen CD","year":"2003","unstructured":"Cohen CD, Horster S, Sander CA, Bogner JR. Kaposi's sarcoma associated with tumour necrosis factor alpha neutralising therapy. Ann Rheum Dis. 2003, 62:684. 10.1136\/ard.62.7.684","journal-title":"Ann Rheum Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2013.15.154.2988","article-title":"Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient","volume":"15","author":"Hamzaoui L","year":"2013","unstructured":"Hamzaoui L, Kilani H, Bouassida M, et al.. Iatrogenic colorectal Kaposi sarcoma complicating a refractory ulcerative colitis in a human immunodeficiency negative-virus patient. Pan Afr Med J. 2013, 15:154. 10.11604\/pamj.2013.15.154.2988","journal-title":"Pan Afr Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.04.016","article-title":"Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab","volume":"10","author":"Ursini F","year":"2010","unstructured":"Ursini F, Naty S, Mazzei V, Spagnolo F, Grembiale RD. Kaposi's sarcoma in a psoriatic arthritis patient treated with infliximab. Int Immunopharmacol. 2010, 10:827-828. 10.1016\/j.intimp.2010.04.016","journal-title":"Int Immunopharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5606\/ArchRheumatol.2018.6695","article-title":"Aggressive Kaposi's sarcoma associated with golimumab therapy","volume":"33","author":"Vural S","year":"2018","unstructured":"Vural S, G\u00fcndo\u011fdu M, Akay BN, et al.. Aggressive Kaposi's sarcoma associated with golimumab therapy. Arch Rheumatol. 2018, 33:384-386. 10.5606\/ArchRheumatol.2018.6695","journal-title":"Arch Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2012.01523.x","article-title":"Kaposi's sarcoma associated with treatment with adalimumab","volume":"25","author":"Amadu V","year":"2012","unstructured":"Amadu V, Satta R, Montesu MA, Cottoni F. Kaposi's sarcoma associated with treatment with adalimumab. Dermatol Ther. 2012, 25:619-620. 10.1111\/j.1529-8019.2012.01523.x","journal-title":"Dermatol Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2009.10.006","article-title":"Kaposi's disease in a patient on adalimumab for rheumatoid arthritis","volume":"76","author":"Bret J","year":"2009","unstructured":"Bret J, Hernandez J, Aquilina C, Zabraniecki L, Fournie B. Kaposi's disease in a patient on adalimumab for rheumatoid arthritis. Joint Bone Spine. 2009, 76:721-722. 10.1016\/j.jbspin.2009.10.006","journal-title":"Joint Bone Spine"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5114\/ada.2016.59163","article-title":"Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis","volume":"33","author":"Bergler-Czop B","year":"2016","unstructured":"Bergler-Czop B, Brzezi\u0144ska-Wcis\u0142o L, Kolanko M. Iatrogenic Kaposi's sarcoma following therapy for rheumatoid arthritis. Postepy Dermatol Alergol. 2016, 33:149-151. 10.5114\/ada.2016.59163","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/51108-iatrogenic-kaposi-sarcoma-precipitated-by-anti-tumor-necrosis-factor-alpha-anti-tnf--therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:39Z","timestamp":1707506979000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/51108-iatrogenic-kaposi-sarcoma-precipitated-by-anti-tumor-necrosis-factor-alpha-anti-tnf--therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.13384","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}